RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Bullous Pemphigoid: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Clarifying denominators and statistical reporting in methotrexate maintenance for bullous pemphigoid.
Zhu Xiao, The British journal of dermatology (19 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42592827/
- 2.
Bullous Pemphigoid in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Study of 1,067 Cases.
Kawama Kentaro et al., Internal medicine (Tokyo, Japan) (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42875203/
- 3.
Suspected Rosuvastatin-Associated Bullous Pemphigoid: A Diagnostic and Therapeutic Challenge.
Gandhi Shirley et al., American journal of therapeutics (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42875850/
- 4.
Baseline Serum Thymus and Activation-Regulated Chemokine Levels and 1-Year Relapse in Bullous Pemphigoid: A Retrospective Cohort Study.
Kitayama Shohei et al., The Journal of dermatology (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42885110/
- 5.
Disease-specific and therapy-driven alterations in immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells from pemphigus vulgaris and bullous pemphigoid patients.
Zhou Wenyu et al., Molecular immunology (13 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42868828/
Clinical Trials : Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
NCT06371417 · Recruiting · Phase 1 · Chugai Pharmaceutical
Ages 18 to 85
https://clinicaltrials.gov/study/NCT06371417
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Bullous Pemphigoid
Bullous pemphigoid is a rare autoimmune skin disease in which the immune system attacks proteins that hold the layers of skin together. It causes itchy rashes and large, tense, fluid-filled blisters, mostly in older adults. Treatment usually involves topical or oral corticosteroids and other medicines that calm the immune system.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Bullous Pemphigoid?
Bullous pemphigoid is a rare autoimmune skin disease in which the immune system attacks proteins that hold the layers of skin together. It causes itchy rashes and large, tense, fluid-filled blisters, mostly in older adults. Treatment usually involves topical or oral corticosteroids and other medicines that calm the immune system.
How many clinical trials are available for Bullous Pemphigoid?
RareWays currently indexes 37 clinical trials for Bullous Pemphigoid, of which 1 is actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Bullous Pemphigoid come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Bullous Pemphigoid.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.